Clindamycin is an antibiotic derived from soil.

The ingredient was developed in the late 1960’s and first approved by the FDA in 1970 as a skincare treatment for bacterial infections. It gained similar approval in the UK in 1975.

Clindamycin significantly influenced dermatology practices by becoming a cornerstone prescription topical treatment in the battle against acne and antibiotic-resistant skin infections.